• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Lupin Gets US FDA Approval for Lamotrigine Tablets

      Posted AtNasdaq.com

      MUMBAI -(Dow Jones)- Indian generic drug maker Lupin Ltd. (500257.BY) said Friday its U.S. unit has received final approval from the U.S Food and Drug Administration to make and sell Lamotrigine tablets.

      The approval is for tablets in strengths of 25 milligrams, 100 mg, 150 mg and 200 mg, the company said in a filing to the Bombay Stock Exchange.

      Lamotrigine is the generic form of GlaxoSmithKline's (GSK) Lamictal tablets and is used for the treatment of epilepsy and bipolar disorder.

      Lamotrigine tablets have annual U.S. sales of about $452 million, the company said, citing data from IMS Health market research.

      June 16, 2010


      Share this Article!

    Back to top^